👉 Not a scientist, just a nuisance 👈
Named: ‘Perpetrator 1’ by @sciguardians.bsky.social
[email protected]
Kevin Patrick IRL
COSIG (32 guides and growing!) is available at cosig.net.
pubpeer.com/publications... h/t anon Hoya.
pubpeer.com/publications... h/t anon Hoya.
Some of the SciGuardians gang thinks posting nonsensical comments on the Retraction Watch site will accomplish something. These people never progressed beyond playground taunts.
retractionwatch.com/2025/11/21/e...
Some of the SciGuardians gang thinks posting nonsensical comments on the Retraction Watch site will accomplish something. These people never progressed beyond playground taunts.
retractionwatch.com/2025/11/21/e...
A 2024(!) travesty of a paper courtesy of @elsevierconnect.bsky.social's Translational Oncology journal and researchers in China.
pubpeer.com/publications...
A 2024(!) travesty of a paper courtesy of @elsevierconnect.bsky.social's Translational Oncology journal and researchers in China.
pubpeer.com/publications...
@elisabethbik.bsky.social @lonnibesancon.bsky.social @thatsregrettab1.bsky.social
Un groupe anonyme sévit sur les réseaux depuis un an, ciblant principalement les détectives de la littérature scientifique : les ScienceGuardians
Notre enquête : themeta.news/les-scienceg...
#VeilleESR #ResearchIntegrity
@elisabethbik.bsky.social @lonnibesancon.bsky.social @thatsregrettab1.bsky.social
But a new paper argues the claim rests on shaky foundations. https://scim.ag/48lckEh
But a new paper argues the claim rests on shaky foundations. https://scim.ag/48lckEh
There's a duplicated ß-actin band (green).
The author replies, "Because Smad3 is already the right loading control for p-Smad3, thus the last beta-actin is not necessary and we will contact the journal for removal."
Is this legit? 😕
pubpeer.com/publications...
There's a duplicated ß-actin band (green).
The author replies, "Because Smad3 is already the right loading control for p-Smad3, thus the last beta-actin is not necessary and we will contact the journal for removal."
Is this legit? 😕
pubpeer.com/publications...
Ivan Oransky @retractionwatch.com will talk about 'Summing up: What to do next?'
If a headline is a question, the answer is no!
#IRICSydney
Ivan Oransky @retractionwatch.com will talk about 'Summing up: What to do next?'
If a headline is a question, the answer is no!
#IRICSydney
"The retraction has been agreed following an investigation of the concerns raised by Penicillium citreoviride (ImageTwin) and Actinopolyspora biskrensis (me) on PubPeer, which identified concerns regarding Figures 2 and 3."
pubpeer.com/publications...
"The retraction has been agreed following an investigation of the concerns raised by Penicillium citreoviride (ImageTwin) and Actinopolyspora biskrensis (me) on PubPeer, which identified concerns regarding Figures 2 and 3."
pubpeer.com/publications...
retractionwatch.com/2025/11/14/b...
retractionwatch.com/2025/11/14/b...
pubpeer.com/publications...
pubpeer.com/publications...
COSIG's entry on formulaic research now covers low-quality pharmacovigilance studies!
COSIG's entry on formulaic research now covers low-quality pharmacovigilance studies!
(and please repost this for a snowball effect!)
(and please repost this for a snowball effect!)
pubpeer.com/publications...
pubpeer.com/publications...
statmodeling.stat.columbia.edu/2025/11/12/b...
statmodeling.stat.columbia.edu/2025/11/12/b...
retractionwatch.com/2024/08/06/p...